Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website

Case Report

Volume 11, Number 1, January 2020, pages 30-33

Gemcitabine-Related Acute Coronary Syndrome


Table 1. Summary of Reported Cases of Gemcitabine-Related Acute Coronary Syndrome
AuthorReported eventAge, gender, malignancy (origin, stage)Duration of therapyDoseCardiac historyInterval time (after infusion)OutcomeAssociation
F: female; CMP: cardiomyopathy; CAD: coronary artery disease; NSTEMI: non-ST-segment elevation myocardial infarction; VT: ventricular tachycardia; IV: stage IV cancer; NK: not known; M: male; AF: atrial fibrillation; IIA: stage IIA cancer; CABG: coronary artery bypass graft.
Ozturk et al [4]Coronary vasospasm59, F, uterus, IVSecond cycle900 mg/m2CAD30 minSurvivedStrong
Bdair et al [5]NSTEMI/VT43, F, lung, IVFifth cycle1,000 mg/m2CMP, CAD3 daysSurvivedStrong
Katircibasi et al [6]Coronary vasospasm64, F, ovary, IVSecond cycleNKNo30 minSurvivedStrong
Kalapura et al [7]NSTEMI, AF54, M, pancreas, IVFifth cycle1,900 mg/m2No6 hSurvived; AF recurredStrong
Present case 1NSTEMI68, M, lung, IVFirstt cycle1,950 mg/m2No5 daysSurvivedStrong
Present case 2NSTEMI/cardiogenic shock84, M, pancreas, IIASecond cycle1,950 mg/m2CAD, CABG2 hSurvivedStrong